Cailes J B, O'Connor C, Pantelidis P, Southcott A M, Fitzgerald M X, Black C M, du Bois R M
Royal Brompton Hospital, London, UK.
Eur Respir J. 1996 May;9(5):992-9. doi: 10.1183/09031936.96.09050992.
Fibrosing alveolitis complicating systemic sclerosis (FASSc) carries a better prognosis than lone cryptogenic fibrosing alveolitis (CFA). We wanted to determine whether this improved prognosis is associated with differential neutrophil migration and activation in the lower respiratory tract. We therefore compared bronchoalveolar lavage (BAL) neutrophil numbers and levels of neutrophil-derived enzymes in FASSc, CFA and normal individuals. Bronchoalveolar lavage was performed on 45 subjects (FASSc n = 20; CFA n = 15; normals n = 10); cell counts and levels of neutrophil-derived enzymes, myeloperoxidase, elastase (total elastase and elastase/alpha 1 antitrypsin complexes), collagenase and lactoferrin were measured. Lung function testing was performed in subjects with fibrosing alveolitis. Significant differences in the levels of collagenase, myeloperoxidase and elastase/ alpha 1-antitrypsin complexes were present in the BAL fluid from the three groups. Patients with CFA had significantly higher neutrophil percentages and levels of collagenase and myeloperoxidase than those with FASSc. Disease extent, as judged by lung volumes and gas transfer, was comparable in the CFA and FASSc groups. Forced vital capacity (% predicted) was significantly lower in patients with evidence of increased neutrophil enzyme release than those without. We conclude that: 1) increased neutrophil migration to the lung is accompanied by release both of primary and secondary granule enzymes in cryptogenic fibrosing alveolitis; and 2) the lower amounts of neutrophil products in fibrosing alveolitis complicating systemic sclerosis may account for the improved prognosis, even when disease is as extensive as in cryptogenic fibrosing alveolitis.
合并系统性硬化症的纤维化肺泡炎(FASSc)的预后比特发性隐源性纤维化肺泡炎(CFA)更好。我们想确定这种改善的预后是否与下呼吸道中性粒细胞的不同迁移和激活有关。因此,我们比较了FASSc、CFA和正常个体的支气管肺泡灌洗(BAL)中性粒细胞数量以及中性粒细胞衍生酶的水平。对45名受试者进行了支气管肺泡灌洗(FASSc组20例;CFA组15例;正常组10例);检测了细胞计数以及中性粒细胞衍生酶、髓过氧化物酶、弹性蛋白酶(总弹性蛋白酶和弹性蛋白酶/α1抗胰蛋白酶复合物)、胶原酶和乳铁蛋白的水平。对患有纤维化肺泡炎的受试者进行了肺功能测试。三组的BAL液中胶原酶、髓过氧化物酶和弹性蛋白酶/α1 -抗胰蛋白酶复合物水平存在显著差异。CFA患者的中性粒细胞百分比以及胶原酶和髓过氧化物酶水平显著高于FASSc患者。根据肺容积和气体交换判断的疾病程度,在CFA组和FASSc组中相当。有中性粒细胞酶释放增加证据的患者的用力肺活量(预测值%)显著低于无此证据的患者。我们得出结论:1)在隐源性纤维化肺泡炎中,中性粒细胞向肺的迁移增加伴随着初级和次级颗粒酶的释放;2)合并系统性硬化症的纤维化肺泡炎中较低的中性粒细胞产物量可能是预后改善的原因,即使疾病程度与隐源性纤维化肺泡炎相同。